Pathological Pattern of Intrahepatic HBV in HCC is Phenocopied by PDX-Derived Mice: a Novel Model for Antiviral Treatment
BACKGROUND: Hepatitis B virus (HBV) is one of the most prominent risk factors for hepatocellular carcinoma (HCC) development and virus-mediated cases represents more than 80% of HCC in East Asia, where it is endemic. Currently, the HBV status of pathological HCC is not fully clarified, especially by...
| Main Authors: | Jiao Liu, Siyuan Chen, Zhe Zou, Dehong Tan, Xiangde Liu, Xing Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2019-09-01
|
| Series: | Translational Oncology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523319301159 |
Similar Items
-
Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC
by: Vicki Wing-Ki Hui, et al.
Published: (2020-12-01) -
Antiviral Treatments Eliminate the Adverse Impacts of High Baseline HBV Loads on the Survival of HBV-Related HCC Patients
by: Hu Z, et al.
Published: (2022-04-01) -
Unveiling NUSAP1 as a common gene signature linking chronic HBV infection and HBV-related HCC
by: Jiao Meng, et al.
Published: (2024-03-01) -
Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis
by: François Villeret, et al.
Published: (2023-06-01) -
A comparative study of clinicopathological and imaging features of HBV-negative and HBV-positive intrahepatic cholangiocarcinoma patients with different pathologic differentiation degrees
by: Xiaoli Huang, et al.
Published: (2023-11-01)